Male breast cancer
Exam relevance: in 1 of more than 150 board exam reports · rank 171
- Specialty
- Gynaecology · Breast
- Images
- Histology & cytology 2
- Exam relevance
- 1 of more than 150 reports · rank 171
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (2)
Histology & cytology
Histology & cytologyOccurrence & epidemiology
Epidemiology
- Male breast cancer is rare: fewer than 1% of all breast cancers occur in men.
- The mean age at diagnosis is between 60 and 70 years, but men of any age can be affected.
Aetiopathogenesis
Aetiology and risk factors
- Risk factors are older age, breast cancer in female relatives and germline variants in BRCA2 or BRCA1, the risk being higher with BRCA2.
- Variants in PTEN, TP53 (Li-Fraumeni syndrome) and PALB2 are also discussed.
- Raised oestrogen levels, for example in Klinefelter syndrome, liver cirrhosis, obesity or testicular conditions such as orchitis and undescended testis, and previous exposure of the chest to ionising rays increase the risk.
Clinical features
- Most present with a retroareolar mass; other signs are nipple retraction, bleeding from the nipple, skin ulceration, peau d’orange and palpable axillary lymph nodes.
- Because of diagnostic delay, breast cancer in men is more often found at an advanced stage.
Histology
- The commonest type is invasive ductal carcinoma, while invasive lobular carcinoma is very rare.
- Almost all tumours are hormone receptor positive; in one series 99% were oestrogen receptor positive, 82% progesterone receptor positive and 9% HER2 positive.
Diagnosis
- Imaging comprises mammography and ultrasound; suspicious findings are confirmed by core biopsy, and oestrogen receptor, progesterone receptor and HER2 are assessed on tumour tissue.
Treatment principles
- Treatment largely follows the principles used for breast cancer in women and is decided in the tumour board.
- Mastectomy is the usual operation, with sentinel lymph node biopsy to assess the axilla; radiotherapy and chemotherapy follow according to the findings.
- As these tumours are almost always hormone receptor positive, endocrine therapy is central, primarily with a selective oestrogen receptor modulator; because of the frequent BRCA2 association, genetic counselling is offered.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Pregnancy-associated breast cancer · Non-puerperal mastitis · Fibrocystic breast changes and breast cysts
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.